Home » Newsletters » BioWorld Science

BioWorld Science

April 4, 2022

View Archived Issues

Novel TLR4 murine model to study dermal sensitization by nickel salts

AZD-9574: a selective PARP1 inhibitor suitable for cancer treatment

New hederagenin derivatives display multidrug resistance reversal in tumors

AIMer RNA base editing oligonucleotides edit ACTB transcript in the liver of nonhuman primates

Sichuan Haisco Pharmaceutical patents JAK3 inhibitors

Shanghai Haiju Biotechnology divulges new platinum complexes for cancer

New Mat2A inhibitors synthesized by ScinnoHub Pharmaceutical

Merck & Co. presents new KLKB1 inhibitors

Shanghai Litedd presents new RET inhibitors

LY-3372689, a novel OGA enzyme inhibitor for the treatment of Alzheimer's disease

Discovery of alpha-syn aggregation inhibitors for the treatment of PD

Researchers present [11C]JMJ-81 as a new PET tracer for brain PDE4D quantification

JS-009 cleared to advance into clinic in U.S. for advanced solid tumors

Blockade of PTGDR protects mice from severe SARS-CoV-2 infection

Molecular chaperone maintains proteostasis by clearing protein aggregates in cell

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...